CDK16 and breast carcinoma: In this study, we investigated the clinical relevance of CDK16 in the prognosis of breast cancer patients, and revealed that CDK16 is highly expressed in breast cancers, especially TNBC, and its elevated expression is correlated with poor prognosis.